Introduction

▼
Nanoparticle-based drug delivery systems off er numerous privileges including targeting the drug into the potential active site, thus decreasing its side eff ect, controlling the release of the drug at the active site and increasing the drug uptake. Also they produce some excellent pharmacokinetic properties leading to enhance the drug absorption and distribution. Application of nanoparticles in the delivery of nucleotides into their active sites has been the subject of several researches in the past few decades [ 1 ] . Gene therapy, as a new and promising way to treat some of most complicated health disorders, is defi ned as the transfer of a genetic material into a cell for therapeutic benefi ts [ 2 ] . Generally, there are 2 types of gene delivery systems including viral and non-viral. Although viral gene delivery systems possess high effi ciency in various human tissues, they have some limitations like immunogenicity, toxicity and possible viral gene integration into the human genome. On the other hand, capacity to effi ciently deliver the gene of interest into cells is still limited. It can be due to some reasons such as undefi ned physical shapes, dissociation of the complexes in the presence of anions and a limited capacity to co-associate other functional molecules [ 7 ] . Cyclodextrins are a family of cyclic oligosaccharides which consists of (α-1,4)-linked α-D-glucopyranose unit with a hydrophilic outer surface and a lipophilic central cavity [ 8 ] . Cyclodextrins present many advantages as potential core molecules for the development of nonviral vectors [ 9 -13 ] . Indeed new generations of polysaccharide nanocarriers consisting of chitosan and cyclodextrins have been developed in recent years to use the promising behavior of chitosan nanoparticles with the excellent biopharmaceutical properties of cyclodextrin [ 7 ] . The objective of the present study was to prepare chitosancyclodextrin-plasmid DNA nanoparticles encoding interleukin-12 that has been proved to possess antitumor eff ects via stimulating the immune system. Also the physicochemical characteristic as well as cytotoxicity of the prepared formulations were evaluated against the CT-26 colon carcinoma cell line. 
Materials and Methods
▼
Preparation and characterization of low molecular weight chitosan
The low molecular weight CS (LMW CS) was prepared by oxidative degradation with NaNO 2 at room temperature. Briefl y, 1 % (w/v) CS was dissolved in 1 % HAc solution, consequently an appropriate amount of 0.1 M NaNO 2 was added dropwise and the reaction was performed at room temperature for 3 h and 24 h, respectively. The reaction mixture was subsequently neutralized with 1 N NaOH to pH 8.0 to precipitate CS. The precipitated CS was recovered by centrifugation, washed several times with deionized water, and dried [ 14 ] . Viscosities of prepared CS samples in 0.2 M HAc/0.1 M NaAc were measured using an Ubbelohde capillary viscometer (Model Schott mainz, Germany) in a constant-temperature of 30 ± 0.01 °C. Solution concentrations were adjusted based on the viscosity of the samples and the fl ow through time was kept in the range of 100-150 s. 5 diff erent concentrations were tested for each sample. The intrinsic viscosity was determined by the intercept of Huggins (ηsp/C ~ C) plot on the ordinate at C = 0. Finally the molecular weight of each sample was calculated based on the classical Mark-Houwink equation:
is the intrinsic viscosity of the depolymerized CS, K and a are constants for given solute-solvent system and temperature. For CS, they are infl uenced by the degree of deacetylation, pH, and ionic strength of the solvent [ 14 ] . According to our solvent system (0.2 M HAc/0.1 M NaAc), k and α were 0.000104, 0.001424 and 1.12, 0.96 for 69 and 84 degree of deacetylation, respectively [ 15 ] .
Preparation of LMW CS/CD nanoparticles
Nanoparticles were obtained by ionotropic gelation Method according to Alonso et al. [ 7 ] . 2 aqueous phases containing: (1) LMW CS solution (2 mg/ml), and (2) CD solution (20 mg/ml) containing 3 mg/ml TPP as cross-linker, were mixed under vortexing for 10 min. For nanoparticles encapsulating the pDNA, the required amount of the plasmid pUMVC3-hIL12 was incorporated directly into the CD/TPP phase [ 7 ] . To this end, plasmid DNA was fi rstly extracted from transformed E.coli (DH5-α), then the concentration of purifi ed plasmid DNA was determined at 260 nm using nanodrop spectrophotometer.
Physicochemical characterization of the pUMVC3-hIL12 loaded LMW CS/CD nanoparticles
Evaluation of particle size, polydispersity index, and zeta potential of the pUMVC3-hIL12 loaded LMW CS/CD nanoparticles were performed by zetasizer nano particle analyzer (Nano ZS, Red badge, ZEN3600). Particle morphology of the selected pUMVC3-hIL12 loaded LMW CS/CD nanoparticles was determined by transmission electron microscopy (TEM). One drop of LMW CS/CD nanoparticles was placed on a copper grid and stained with 1 % uranyl acetate solution for 5 s. The grid was allowed to dry further for 10 min and was then examined with the electron microscope (LEO 906, Germany). The amount of plasmid DNA encapsulated in the LMW CS/CD nanoparticles was calculated by considering the diff erence between the total amount of DNA added into the preparation medium through the coacervation process and the amount of non-entrapped DNA remaining in the supernatant after centrifugation (12 000 RPM, for 30 min, at 4 °C) of prepared nanoparticles. For this purpose, the supernatant was spectrophotometrically analyzed at 260 nm for DNA concentration [ 16 ] .
Evaluation of cytotoxicity
Cytotoxicity of the pUMVC3-hIL12 loaded LMW CS/CD nanoparticles was evaluated by the MTT based cytotoxicity assay in murine CT-26 colon carcinoma cells. MTT assay is based on the ability of living cells to reduce MTT, a water-soluble yellow dye, to a purple colored formazan precipitates product by mitochondrial reductase enzymes. The cells were seeded in a 96-well plate at a density of 5 × l0 4 cells/cm 2 in100 μl of RPMI-1640 medium supplemented with 10 % FBS and incubated for 24 h at 37 °C under 5 % CO 2 . Afterward, the medium was removed and supplied with 200 μl of fresh culture medium. Subsequently, pDNA loaded LMW CS/CD nanoparticles were added to the cells at a serial dose of 1.6, 0.8, 0.4, 0.2, 0.1, 0.05, 0.025 μg pUMVC3-mIL12/μl. Non-treated cells as well as and cells treated with lipofectamine TM were used as controls and incubated for the same duration of time. Following 24 h of incubation at 37 °C under 5 % CO 2 , the medium was removed and fresh cell culture medium was added, then the cells were incubated with 20 μl MTT (0.5 mg/ml MTT in medium) for 4 h. Subsequently the medium was removed, and the formazan precipitates formed in living cells were dissolved in 200 μl DMSO and 25 μl Sorenson buff er per well. Relative viability ( %) was calculated based on absorbance at 570 nm using an ELISA plate reader. Viability of non-treated control cells was arbitrarily defi ned as 100 %. The relative cell viability was calculated as [Abs] sample /[Abs] control × 100. Data were presented as mean ± SD (n = 4). This document was downloaded for personal use only. Unauthorized distribution is strictly prohibited.
In vitro transfection studies
Murine CT-26 colon carcinoma cells were seeded into 24-well plates at a density of 80 000 cells/well in 1 ml of RPMI-1640 medium supplemented with 10 % FBS and incubated for 24 h at 37 °C under 5 % CO 2 . Prior to transfection, the medium was removed and the cells were rinsed with PBS (pH 7.4), then supplied with 900 μl of RPMI-1640 medium without FBS. The cells were incubated with pDNA loaded LMW CS/CD nanoparticles at concentrations range of 0.025 to 0.8 μg/ml for 6 h at 37 °C under 5 % CO 2 . Subsequently, the serum-free medium was removed and the wells were washed with PBS. Fresh medium (RPMI-1640 containing 10 % FBS) was then added to each well. The cell culture plate was incubated for another 48 h at 37 °C under 5 % CO 2 .
Non-treated cells and cells transfected with naked plasmid (as negative controls) were used and incubated for the same duration of time. All experiments were done in triplicates, with 3 separate experiments to demonstrate reproducibility. For quantitative analysis of the pUMVC3-hIL12 expression, the human IL-12p70 enzyme-linked immunosorbent assay (ELISA) Kit was used according to the manufacturer's instructions. For this purpose, the collected culture supernatants were analyzed for the measurement of hIL-12 p70. The amount of the protein was determined as picogram per ml.
Results
▼
Preparation and characterization of low molecular weight chitosan
The LMW CS was prepared by oxidative degradation with 0.1 M NaNO 2 at room temperature using 1 % (w/w) CS dissolved in 1 % HAc solution. Fig. 1 .
The pUMVC3-hIL12 loaded LMW CS/CD nanoparticles formation and characterization
LMW CS/CD nanoparticles were prepared by ionotropic gelation in the presence of TPP, as described in the methodology section. The average size, polydispersity index and Zeta potential of pUMVC3-hIL12 loaded LMW CS/CD nanoparticles are given in • ▶ Table 2 and depicted in • ▶ Fig. 2 . Also the amount of DNA loaded in the nanoparticles was calculated as encapsulation efficiency ( %) which is shown in • ▶ Table 2 .
A typical transmission electron microscopy (TEM) image of F1 is shown in • ▶ Fig. 3 . As can be seen from this fi gure, the particles were nano-sized and spherical in shape.
Evaluation of cytotoxicity and viability
The cell toxicity of pUMVC3-hIL12 loaded LMW CS/CD nanoparticles was investigated by MTT-based cytotoxicity assay in murine CT-26 colon carcinoma cells. The prepared polyplexes showed no cell toxicity in murine CT-26 colon carcinoma cells.
The average cell viability determined using MTT assay for Table 2 Formulation, particle size, polydispersity index, and zeta potential of pUMVC3-hIL12 loaded LMW CS\CD nanoparticles. diff erent DNA concentrations ranged from 97.7 ± 5 to 126.8 ± 23 ( • ▶ Fig. 4 ). In contrast, Lipofectamine/IL-12 complexes as a control resulted in less than 60 % cell viability.
In vitro transfection studies • ▶ Fig. 5 compares the transfection effi ciencies of the pUMVC3-hIL12 loaded LMW CS/CD nanoparticles in diff erent concentrations in CT-26 carcinoma cells. Untreated CT-26 cells showed no production of Il-12. At plasmid concentrations below or above 0.1 μg/ml, the transfection effi ciencies of pUMVC3-hIL12 loaded LMW CS/CD nanoparticles were not remarkably diff erent from that of the naked DNA. At the concentration of 0.1 μg/ml, the transfection ability was obviously higher than that of the naked DNA.
Discussion
▼
Immunotherapy-based strategies for cancer therapy try to increase the local and systemic immune response against the cancer cells and possibly provide a less toxic approach. IL-12 has been shown to have superior antitumor activity compared to other cytokines. To get optimal results, cytokines are required to be available over an extended period of time, which is not possible with IL-12 protein owing to its short half-life [ 17 ] . According to the several studies reported in this area, polymeric vectors like CS, release their payload in a sustained manner [ 1 ] . Hence, we hypothesized that gene therapy using pUMVC3-hIL12 loaded LMW CS/CD nanoparticles possibly provide noteworthy advantages over protein therapy due to the potential ability of polymeric based nanoparticles to produce sustained levels of IL-12 in the tumor location. Based on the previous studies in this regard, LMW CS showed the ability to effi ciently interact with the pDNA [ 7 ] . Thus CS in the molecular weight of 12-32 KDa prepared by oxidative degradation method was used in this study. pUMVC3-hIL12 loaded LMW CS/CD nanoparticles were prepared via ionotropic gelation method which is simple, quick, economical, and requires no toxic solvents compared to the other approaches [ 1 ] . The electrostatic interaction between positively charged CS and negatively charged DNA and CD is involved in the nanoparticle formation. Furthermore, the ability of CS to undergo a liquid-gel transition due to its ionic interaction with TPP is of importance in the process. The maximum LMW CS/CD/ TPP mass ratio to produce optimum nanoparticle characterization was chosen to be 6/1/1 (w/w) according to Teijeiro-Osorio et al. [ 7 ] . Following the preparation of the nanoparticles, they were characterized in terms of size, zeta potential, morphology, loading effi ciency, cytotoxicity, and fi nally transfection efficiency. As shown in • ▶ Fig. 2 , 3 , all particles were nano-sized (171.3 ± 2.165 nm, PdI: 0.231 ± 0.014) and exhibited positive zeta potential (34.3 ± 1.55). In general, zeta potential is one of the important particle characteristics, because more pronounced zeta potential values lead to stabilization of the particle suspension due to the electrostatic repulsion between particles with the same electric charge which prevents aggregation [ 18 ] . Furthermore, the positively charged particles can facilitate adherence to negatively charged cellular membranes which will induce and increase intracellular uptake [ 19 , 20 ] . Alonso et al. prepared ionically crosslinked nanoparticles based on LMW CS (10KDa) with plasmid DNA and TPP at the same ratio of CS/TPP (6/1/1). Based on their results, the size of prepared particles were in the range of 109 ± 13 to 165 ± 10 and zeta potential of 7.7 ± 0.4 to 10.8 ± 4.2. Also in cytotoxicity test, they were non toxic. In comparison with these results and ours, it is obvious that there are no considerable diff erences in the physicochemical properties and cytotoxicity of LMW CS/TPP (6/1) nanoparticles with LMW CS/CD/TPP (6/1/1) nanoparticles [ 21 ] . The mean encapsulation effi ciency of our prepared nanoparticles for DNA was 83.31 % as shown in • ▶ Table 2 . The high encapsulation effi ciency is observed in the previous studies for other CS nanoparticles which might be due to the high affi nity of CS to DNA [ 22 ] .
It is important to evaluate the toxicity of the prepared nanoparticles in a cell line model. MTT assay is a quantitative colorimetric method to determine cell proliferation and it utilizes the yellow tetrazolium salt which is metabolized by mitochondrial succinic dehydrogenase activity of proliferating cells. The ability of cells to reduce MTT provides an indication of the mitochondrial integrity and activity, which, in turn, may be interpreted as a measure of viability. Comparison of results between control and test cultures provides an indication of the cytotoxic eff ect of test compounds [ 14 ] . The eff ect of diff erent CS derivatives as well as CS/CD complexes on the viability of tumor cells has been extensively studied so far (26) (27) (28) (29) and some controversial results have been reported. Some studies reported no toxicity against the tested cell lines at the used concentrations, both for CS or CS/ CD complexes [ 7 ] ; whereas, other studies reported the inhibition of the growth of tumor cell in the presence of CS or its derivatives [ 23 , 24 ] . Also, there are few reports about the stimulation eff ect of CS, for example, Dhiman and coworkers showed that the reduction percentage of MCF-7 cells brought by Tamoxifen in the presence and absence of CS are 15 % and 50 % respectively, indicating strong stimulation (inhibition of reduction) of the selected cell lines [ 25 ] . Also, in another study [ 26 ] , the stimulation eff ect of CS on orchid meristem culture and orchid protocorm propagation was reported. Prepared pUMVC3-hIL12 loaded LMW CS/CD/TPP nanoparticles showed no cell toxicity with average cell viability of almost over 97 % in murine CT-26 colon carcinoma cells (97.7 ± 5 to 126.8 ± 23) that was significantly higher than the average cell viability of lipofectamine treated cells (58.2 ± 9.5). Even the viability percentages of the tested cells were increased by about 120 % in the case of 1.6 and 0.8 μg/ml. Having low toxicity will make it possible to increase the dose of these nanoparticles or use repeated administrations. Based on the studies reported for the in vitro release properties of polymeric vectors like CS, a sustained manner has been reported [ 1 ] . Nevertheless, the in vitro release studies can be a representative of the in vitro stability of the particles, rather than in situ release behavior. Since the intracellular release condition is completely diff erent, so the in vitro release studies cannot mimic the real conditions inside the cells. Consequently, we decided to study the eff ect of our prepared nanoparticles on the expression of Il-12, as a correct way to fi nd an idea about the intracellular release behavior as well as the transfection efficiency. CT-26 colon carcinoma cells as cancer cells which are less immunogenic have been widely used for the study of the anti-tumor activity of IL-12. According to our results which is depicted in • ▶ Fig. 5 , CT-26 cell as untreated control showed approximately no production of Il-12 (3.3 pg/ml). On the other hand, following 48h treatment of the cells with IL-12 naked plasmid, 82.3 pg/ml of Il-12 protein was detected using ELISA Kit indicating the transfection of the cells. We tried to evaluate the transfection effi ciencies in longer incubation times, but the best response was obtained in 48 h. The expression study of our prepared nanoparticles was performed by 48h treatment of the cells using diff erent plasmid concentrations. LMW CS/CD/TPP nanoparticles resulted in the highest Il-12 production in murine CT-26 at plasmid concentration of 0.1 μg/ml. This is in agreement with the reported studies using LMW CS/TPP chitosan nanoparticles indicating that the best transfection effi ciency was at an optimum pDNA loading [ 7 , 21 ] . However, there was no signifi cant diff erence between the transfection effi ciency of our prepared nanoparticles and the naked DNA (p > 0.05). This fi nding may be due to several reasons, especially the strong electrostatic interaction between CS and CD, which may prevent prompt intracellular DNA release . Indeed, due to the technical diffi culties like acidity of the medium, prolonged incubation of the cells (more than 48h) was not possible. Hence, the expression amounts of Il-12 in the cells treated with the sustained release nanoparticles and naked plasmid DNA were not properly diff erentiated in short incubation times. Alonso et al. found that the transfection effi ciency of HMW CS/TPP was higher than some versions of HMW CS/CD/ TPP and inclusion of CD into HMW CS/TPP had a negative eff ect in the transfection effi ciency. On the other hand, in the case of nanoparticles prepared using LMW CS, addition of CD enhanced the transfection effi ciency but it was not a massive change [ 7 , 21 ] . Taken together, mild preparation process of DNA complexes using LMW CS/CD/TPP yielded the non-toxic nanoparticles with suitable physicochemical properties. Therefore the prepared LMW CS/CD nanoparticles were selected for in vitro expression studies. In the expression studies in spite of the slight increase in Il-12 at plasmid concentration of 0.1 μg/ml, the diff erences between Il-12 concentration in nanoparticles and naked plasmid DNA were insignifi cant. Further in vivo studies should be performed using animal models to investigate the eff ect of the prepared LMW CS/CD nanoparticles on the IL-12 expression in real conditions.
